ArticleFrontiers in immunology2023

Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers.

Xiaojing Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.